Device and method for in vivo qualitative or quantative measurement of blood chromophore concentration using blood pulse spectrophotometry

• US 5,337,745 A
• Filed: 11/12/1993
• Issued: 08/16/1994
• Est. Priority Date: 03/10/1992
• Status: Expired due to Term

• Current Assignee: Philips Electronics North America Corporation (Koninklijke Philips N.V.)
• Original Assignee: Sextant Medical Corporation
• Inventors: Benaron, David A.
• Primary Examiner(s): Sykes, Angela D.
• Application Number:
  US08/152,913
• Time in Patent Office: 277 Days
• Field of Search: 128/633-634, 128/664-666, 356/39-41
• US Class Current: 600/322
• CPC Class Codes: A61B 5/14532 for measuring glucose, e.g. by tissue impedance measurement
• CPC Class Codes: A61B 5/14546 for measuring analytes not otherwise provided for, e.g. ions, cytochromes
• CPC Class Codes: A61B 5/1455 using optical sensors, e.g. spectral photometrical oximeters

Abstract

An improved spectrophotometer which noninvasively and qualitatively or quantitatively determines the concentration of light and other radiation absorbing substances in the bloodstream inside a radiation scattering body by assessing, at one or more wavelengths, the pulsatile changes which occur with each heartbeat in the absorbance of radiation passing through the medium, whereby the measurement is confined to the blood-stream and the absorbance of material outside of the bloodstream is cancels out. A light emitter (11), consisting of one or more radiation sources (11a, 11b, . . . 11n), emits light into a tissue sample (14) in vivo. Radiation returning to a detector (17) is filtered (21) to remove any nonpulsatile component, amplified (27), demodulated (31) to separate the component of absorbance due to each radiation source. Peak signal intensity is determined (33), and these peak signal values are stored in an absorbance register (37). Solving a matrix of n equations with n unknowns (42) yields the relative absorbance of up to n components in the bloodstream, which are stored in qualitative register (47). Correcting relative concentration (49) using the numbers stored as conversion factors (53) yields the concentration of up to n chromophores, which are stored in quantitative register (51) and displayed on an output device (55).

Claims

1. A spectrophotometer for noninvasively determining the concentration of a first optically absorptive substance within the blood of a patient, comprising:

means for emitting first and second wavelengths of light into a selected tissue of said patient;

means for detecting a first intensity of portions of said first wavelength of light passing through said selected tissue and a second intensity of said second wavelength passing through said selected tissue, said first and second intensities each being related to interaction of said first and second wavelengths of light with a plurality of substances within the blood of said patient, said plurality of substances including said first absorptive substance;

means for measuring a first pulsatile feature of said first detected intensity and a second pulsatile feature of said second detected intensity, said first and second pulsatile features each being related to changes over time in the volume of the blood within said selected tissue; and

means for estimating concentration of said first substance within the blood of said patient based on said first and second measured pulsatile features.

2. The spectrophotometer of claim 1 wherein said means for measuring includes means for filtering constant intensity components from said first and second detected intensities.

3. The spectrophotometer of claim 1 wherein said first and second pulsatile features correspond to changes in at least one of the characteristics of said substances selected from the set consisting of:

absorbance, scattering, transmission, turbidity, coherence, and optical rotation.

4. The spectrophotometer of claim 1 wherein said interaction corresponds to absorbance of said transmitted light by said first substance, and wherein said means for measuring includes means for measuring changes in absorbance of said first and second wavelengths of light by said first substance.

5. The spectrophotometer of claim 1 wherein said means for estimating includes means for solving a set of simultaneous equations relating said first and second measured pulsatile features to relative concentrations of said first substance.

6. The spectrophotometer of claim 1 wherein said means for estimating concentration includes means for estimating concentration of said first substance within arterial blood of said patient.

7. The spectrophotometer of claim 1 wherein said means for estimating concentration includes means for estimating concentration of said first substance within venous blood of said patient.

8. A spectrophotometer for noninvasively determining the concentration of a first optically absorptive substance within the blood of a patient, comprising:

means for transmitting first and second wavelengths of light through a selected tissue of said patient;

means for detecting the intensities of portions of said first and second wavelengths of light passing through said selected tissue, said intensities being related to interaction of said transmitted light with said first substance and with a reference substance within the blood of said patient, said reference substance comprising water;

means for measuring at least one pulsatile feature of said detected intensities, said pulsatile features being induced by changes in the amounts of said absorptive substances within the blood of said patient; and

means for estimating concentration of said first substance within the blood of said patient based on said measured pulsatile features, said means for estimating including

means for computing the ratio of said relative concentration of said first substance to said relative concentration of said reference substance; and

means for adjusting said ratio of said relative concentration in accordance with a calibration factor in order to produce an adjusted ratio;

whereby said adjusted ratio corresponds to absolute concentration of said first substance within the blood of said patient.

9. The spectrophotometer of claim 8 wherein said first substance is selected from the group consisting of:

hemoglobin, bilirubin, glucose, ketones, cholesterol, medications, toxins, and products of human metabolism.

10. A method for noninvasively determining the concentration of a first optically absorptive substance within the blood of a patient, comprising the steps of:

emitting first and second wavelengths of light into a selected tissue of said patient;

detecting a first intensity of portions of said first wavelength of light passing through said selected tissue and a second intensity of said second wavelength passing through said selected tissue, said first and second intensities each being related to interaction of said first and second wavelengths of light with a plurality of substances within the blood of said patient, said plurality of substances including said first absorptive substance;

measuring a first pulsatile feature of said first detected intensity and a second pulsatile feature of said second detected intensity, said first and second pulsatile features each being related to changes over time in the volume of the blood within said selected tissue; and

estimating concentration of said first substance within the blood of said patient based on said first and second measured pulsatile features.

11. The method of claim 10 wherein said step of measuring includes the step of filtering constant intensity components from said first and second detected intensities.

12. The method of claim 10 wherein said first and second pulsatile features correspond to changes in at least one of the characteristics of said substances selected from the set consisting of:

absorbance, scattering, transmission, turbidity, coherence, and optical rotation.

13. The method of claim 12 wherein said interaction corresponds to absorbance of said transmitted light by said first and reference substances, and wherein said step of measuring includes the step of measuring changes in absorbance of said transmitted light by said substances.

14. The method of claim 10 wherein said step of estimating includes the step of solving a set of simultaneous equations relating said first and second pulsatile features to relative concentrations of said first substance.

15. The method of claim 10 wherein said step of measuring said first and second pulsatile features includes the steps of:

measuring a qualitative pulsatile change in the amount of blood within said selected tissue, said pulsatile change being related to the amount of a reference substance in the blood of said patient, said first and second wavelengths of light encountering said reference substance during propagation through said selected tissue, said change occurring proximate a predefined calibration time.

determining an actual concentration of said reference substance in the blood of said patient at a time proximate said calibration time by an independent standard method;

calculating a conversion factor relating said qualitative pulsatile change to said actual concentration; and

converting subsequent pulsatile changes in the amount of said reference substance in the blood to concentrations of said reference substance in the blood in accordance with said conversion factor.

16. The method of claim 15 further including the step of injecting said reference substance into the blood of said patient.

17. A method for noninvasively determining the concentration of a first optically absorptive substance within the blood of a patient, comprising the steps of:

transmitting first and second wavelengths of light through a selected tissue of said patient;

detecting the intensities of portions of said first and second wavelengths of light passing through said selected tissue, said intensities being related to interaction of said transmitted light with said first substance and with a reference substance within the blood of said patient wherein said interaction corresponds to absorbance of said transmitted light by said first and reference substances, and wherein said step of measuring includes the step of measuring changes in absorbance of said transmitted light by said substances, said reference substance comprising water;

measuring at least one pulsatile feature of each of said detected intensities, said pulsatile features being related to changes in the amounts said absorptive substances within the blood of said patient wherein said at least one pulsatile feature corresponds to changes in at least one of the characteristics of said substances selected from the set consisting of;

absorbance, scattering, transmission, turbidity, coherence, and optical rotation, said step of measuring including the step of filtering constant intensity components from said detected intensities; and

estimating concentration of said first substance within the blood of said patient based on said measured pulsatile features, said step of estimating including the steps of;

solving a set of simultaneous equations relating said at least one pulsatile feature to relative concentrations of said first and reference substances;

computing the ratio of said relative concentration of said first substance to said relative concentration of said reference substance; and

adjusting said relative concentration ratio in accordance with a calibration factor;

whereby said adjusted ratio corresponds to absolute concentration of said first substance within the blood of said patient.

18. A method for noninvasively determining the concentration of a first optically absorptive substance within the blood of a patient, comprising the steps of;

transmitting first and second wavelengths of light through a selected tissue of said patient;

detecting the intensities of portions of said first and second wavelengths of light passing through said selected tissue, said intensities being related to interaction of said transmitted light with said first substance and with a reference substance within the blood of said patient wherein said reference substance exhibits a time-invariant concentration;

measuring at least one pulsatile feature of each of said detected intensities, said pulsatile features being related to changes in the amounts said absorptive substances within the blood of said patient, said step of measuring said at least one pulsatile feature including the steps of;

estimating a pulsatile change in the amount of blood within said selected tissue, said pulsatile change being related to the amount of said reference substance within the blood of said patient proximate a first calibration time;

estimating a pulsatile change in the amount of said reference substance within the blood of said patient proximate a second calibration time;

calculating a pulse volume ratio by comparing said estimated pulsatile changes occurring at said first and second calibration times; and

correcting measured pulsatile changes in the amount of said first substance made proximate to said second calibration time in accordance with said pulse volume ratio; and

,

estimating concentration of said first substance within the blood of said patient based on said measured pulsatile features.

19. A method for noninvasively determining the concentration of at least one optically absorptive substance within the blood of a patient, comprising the steps of:

transmitting a plurality of wavelengths of light through a selected tissue of said patient;

detecting the respective intensities of portions of said plurality of wavelengths of light passing through said selected tissue, at least one of said wavelengths of light being selected to be at least partially absorbed by water;

measuring a pulsatile feature of each of said detected intensities, said pulsatile feature of each of said detected intensities being related to changes in the amount of said at least one said optically absorptive substance within the blood of said patient; and

estimating concentration of said at least one said optically absorptive substance within the blood of said patient based on said measured pulsatile features, said step of estimating including the step of calculating a relative amount of water within the blood of said patient based on said measured pulsatile feature of said at least one wavelength of light at least partially absorbed by water.

20. A spectrophotometer for noninvasively determining the concentration of a first optically absorptive substance within the blood of a patient, comprising:

means for emitting first and second wavelengths of light substantially simultaneously into a selected volume of tissue of said patient;

means for detecting the intensities of portions of said first and second wavelengths of light passing through said selected volume of tissue, said intensities being related to interaction of said transmitted light with said first substance and with a reference substance within the blood of said patient;

means for measuring at least one pulsatile feature of each of said detected intensities, said pulsatile features being induced by changes in the volume of blood within said selected volume of tissue wherein said pulsatile features are related to concentration of said absorptive substance within the blood of said patient; and

means for estimating concentration of said first substance within the blood of said patient based on said measured pulsatile features.